Sign up for free insights newsletter
DS

DSM-Firmenich AG

DSFIREuronext Amsterdam

Need professional-grade analysis? Visit stockanalysis.com

€58.12
-2.32%
End of day
Market Cap

$18.41B

P/E Ratio

26.69

Employees

26,873

Dividend Yield

3.42%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-1.75-1.67-1.77-1.73
Calmar-2.35-1.36-0.79-1.37
Sharpe-1.38-1.30-1.40-1.36
Omega0.680.750.740.73
Martin-5.06-3.12-1.48-2.92
Ulcer9.9611.7323.4816.18

DSM-Firmenich AG (DSFIR) Price Performance

DSM-Firmenich AG (DSFIR) trades on Euronext Amsterdam in EUR. The company is classified in the Basic Materials sector under the Specialty Chemicals industry. The stock currently trades at EUR58.12, down 2.32% from the previous close.

Over the past year, DSFIR has traded between a low of EUR55.42 and a high of EUR99.52. The stock has lost 34.4% over this period. It is currently 41.6% below its 52-week high.

DSM-Firmenich AG has a market capitalization of $18.41B, with a price-to-earnings ratio of 26.69 and a dividend yield of 3.42%.

About DSM-Firmenich AG

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. The Animal Nutrition & Health segment offers animal proteins, vitamins, performance solutions, and data-driven precision services. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.

Company Info

Exchange
Euronext Amsterdam
Currency
EUR

Financial Metrics

Revenue (TTM)
$13.01B
EBITDA
$2.21B
Profit Margin
5.52%
EPS (TTM)
2.72
Book Value
81.03

Technical Indicators

52 Week High
€99.92
52 Week Low
€55.30
50 Day MA
€74.54
200 Day MA
€87.99
Beta
0.98

Valuation

Trailing P/E
26.69
Forward P/E
16.42
Price/Sales
1.69
Price/Book
0.83
Enterprise Value
$18.58B